Amarantus Bioscience Holdings Inc (AMBS)

[JLM27]

"As a result of these steps, we are in a position to initiate a partnering process for the CLIA commercial launch of lympro in the second half of 2014."

"As a result of the improvements in these critical areas, the Company initiated a partnering process in the first quarter of 2014 for the CLIA commercial launch of lympro."

"In summary, we have continued to make progress in recent months with our lympro product development program and have put ourselves in a position to develop a meaningful commercialization and marketing partnership for our CLIA assay as we head into the second quarter of 2014."

This is what I like to call discreetly beating someone over the head with information (I strive to do it all the time in my legal writing). He may not have expressly stated that a partnership is forthcoming in the next several months, but almost any informed, engaged reader would have left the blog with that impression.